SERES
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 18 Oct 2024)
What this means for you
Registered since 12 Jun 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 85984347
- Registration number
- 5492370
- Mark type
- Stylized text
- Filed
- 14 Jun 2012
- Published for opposition
- 30 Aug 2016
- Registered
- 12 Jun 2018
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals in the nature of microorganisms for medical use, used to maintain health or restore health to a human subject via treatment of a disturbed microbial community
Owner
- SERES THERAPEUTICS, INC., CAMBRIDGE, MA, US
- SERES THERAPEUTICS, INC., CAMBRIDGE, MA, US
- SERES THERAPEUTICS, INC., CAMBRIDGE, MA, US
- Seres Health, Inc., Cambridge, MA, US
Prosecution history
- 18 Oct 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 18 Oct 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 18 Oct 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Apr 2024 — TEAS SECTION 8 & 15 RECEIVED
- 12 Jun 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 12 Jun 2018 — REGISTERED-PRINCIPAL REGISTER
- 10 May 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 May 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 May 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Apr 2018 — USE AMENDMENT FILED
- 07 May 2018 — DIVISIONAL PROCESSING COMPLETE
- 25 Apr 2018 — DIVISIONAL REQUEST RECEIVED
- 02 May 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Apr 2018 — TEAS REQUEST TO DIVIDE RECEIVED
- 25 Apr 2018 — TEAS STATEMENT OF USE RECEIVED